Purple Biotech Ltd. - American Depositary Shares (PPBT) closed at $1.34 on November 10, 2026, unchanged from the previous close, on volume of 23,482 shares (30-day average 25,881).
Data as of November 10, 2026.
10-Nov-2026
Globe Newswire (Thu, 29-Oct 9:00 AM ET)
Globe Newswire (Wed, 2-Sep 7:30 AM ET)
Market Chameleon (Wed, 29-Oct 5:52 AM ET)
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
Purple Biotech Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol PPBT.
As of November 10, 2026, PPBT stock price was flat at $1.34 with 23,482 million shares trading.
PPBT has a beta of 0.70, meaning it tends to be less sensitive to market movements. PPBT has a correlation of 0.01 to the broad based SPY ETF.
PPBT has a market cap of $1.25 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, PPBT traded as high as $232.00 and as low as $.91.
PPBT has underperformed the market in the last year with a return of -84.2%, while the SPY ETF gained +11.2%. In the last 3 month period, PPBT fell short of the market, returning -10.7%, while SPY returned -2.7%. However, in the most recent 2 weeks PPBT has outperformed the stock market by returning +45.0%, while SPY returned -2.6%.
PPBT support price is $1.24 and resistance is $1.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PPBT shares will trade within this expected range on the day.
